Aridis Pharmaceuticals Stock Price, News & Analysis
Company Description
Welcome to the overview page for Aridis Pharmaceuticals (ARDS), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Aridis Pharmaceuticals (ARDS) currently stands at 25.8 thousand shares, representing 0.1% of the float. Over the past 12 months, short interest has increased by 1460.9%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Aridis Pharmaceuticals (ARDS) currently stands at 3.4 days, up 193.9% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 103.6% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 6.3 days.
